Vanguard Health Care Inv
(VGHCX)
US Markets Closed
AdChoices
217.71
+2.51
+1.17%
:

Previous Close

215.20

Net Assets

10.38B

Yield

1.07%

Front load

None

Expenses

0.35%

Category

Health

Morningstar Risk

Low

Morningstar Rating ★★★★
AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Top Rated Funds
  • Fund vs. Category
Quarterly Returns
  • Annual

  • VGHCX

  • Category

    • 2013

    • 43.19%

    • -

    • 2012

    • 15.11%

    • -

    • 2011

    • 11.45%

    • -

    • 2010

    • 6.16%

    • -

    • 2013

    • 2012

    • 2011

      • Q1

      • 14.43%

      • 7.93%

      • 6.64%

      • Q2

      • 5.00%

      • 1.38%

      • 8.01%

      • Q3

      • 7.56%

      • 5.27%

      • -9.28%

      • Q4

      • 10.80%

      • -0.07%

      • 6.66%

      Composition
      Sector Weightings
      Equity Investment Style
      The two dimensions of the Fund Style box measure the average size of companies that have been in the FUND, from the top to bottom, and the average valuation characteristics of the FUND's past stock holdings, from left to right.
      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Merck & Co Inc

        • 5.01

        • 33,889,948

        • -1,726,900

        • Bristol-Myers Squibb Company

        • 4.49

        • 36,197,961

        • 6,760,200

        • UnitedHealth Group Inc

        • 4.21

        • 20,115,900

        • 349,600

        • Forest Laboratories Inc

        • 3.98

        • 15,716,666

        • -4,867,100

        • AstraZeneca PLC

        • 3.95

        • 20,768,156

        • 1,184,722

        • Eli Lilly and Co

        • 3.50

        • 21,982,700

        • -912,300

        • McKesson Corp

        • 3.14

        • 6,584,000

        • -759,200

        • Vertex Pharmaceuticals Inc

        • 2.86

        • 11,807,500

        • 179,000

        • Roche Holding AG

        • 2.79

        • 3,662,498

        • -497,335

        • Amgen Inc

        • 2.44

        • 8,049,455

        • -164,400

        • Name

        • Rating

        • YTD Return %

          • T. Rowe Price Health Sciences

          • ★★★★★
          • 22.66

          • VALIC Company I Health Sciences

          • ★★★★★
          • 22.36

          • Prudential Jennison Health Sciences A LW

          • ★★★★★
          • 22.77

          • Prudential Jennison Health Sciences Z

          • ★★★★★
          • 23.05

          • Vanguard Health Care Inv

          • ★★★★
          • 21.71

          • Fidelity® Select Biotechnology Portfolio

          • ★★★★
          • 25.03

          • Fidelity Advisor® Biotechnology T

          • ★★★★
          • 24.66

          • Fidelity Advisor® Health Care I

          • ★★★★
          • 24.58

          • BlackRock Health Sciences Opps Inv C

          • ★★★★
          • 20.62

          • Fidelity Advisor® Health Care C

          • ★★★★
          • 23.57

          • Name

          • VGHCX

          • Category

            • Expense Ratio

            • 0.35%

            • 1.45%

            • Net Assets

            • 10.38B

            • 711.24M

            • Dividend Yield

            • 1.48%

            • 0.61

            • Price/Book

            • 2.98

            • 4.82

            • Price/Sales

            • 1.40

            • 3.25

            • Price/Cash Flow

            • 13.82

            • 19.29

            Profile

            Name of Issuer

            Vanguard

            Fund Style

            Open

            Fund Manager

            Jean Hynes

            Investment Style

            Large Growth

            The investment seeks long-term capital appreciation. The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. It may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks.

            Purchase Information

            Initial Purchase 3,000
            Initial Purchase: IRA NA
            Initial Purchase: AIP 0
            Front load None
            Back Load None

            Inception

            5/23/1984